Huiping Liu | Antibody Therapeutic | Best Researcher Award

Dr. Huiping Liu | Antibody Therapeutic | Best Researcher Award

Northwestern University Feinberg | United States

Huiping Liu, MD, PhD, is a distinguished physician-scientist recognized for her pioneering contributions in cancer research, particularly in the fields of breast cancer biology, cancer stem cells, and chemoresistance. She earned her medical and master’s degrees from the Fourth Military Medical University and completed her doctoral studies in biomedical sciences at the University of Chicago. Furthering her training, she pursued postdoctoral research at Stanford University focusing on cancer stem cells in metastasis and later at the University of Chicago investigating microRNAs and chemoresistance. Professionally, she has held academic appointments at Case Western Reserve University before joining Northwestern University Feinberg School of Medicine, where she now serves as an associate professor with tenure, director of the Breast Cancer Research Program, and scientific director of the Circulating Tumor Cell Core. Her research interests include tumor heterogeneity, circulating tumor cells, microRNA regulation, drug resistance mechanisms, and translational approaches to improve cancer therapies. She is highly skilled in molecular oncology, genomics, stem cell biology, translational research, and mentoring emerging scientists. Her honors include recognition as a Chan Zuckerberg Biohub Investigator, membership in the American Society for Clinical Investigation, and multiple awards and research grants from leading organizations. Dr. Liu’s career reflects an enduring commitment to advancing cancer research, shaping future therapies, and training the next generation of scientists.

Profile: Google scholar

Featured Publications

Michela Simone | Boron Neutron Capture Therapy | Best Researcher Award

Dr. Michela Simone | Boron Neutron Capture Therapy | Best Researcher Award

Commonwealth Scientific and Industrial Research Organisation | Australia

Dr. Michela Simone is a distinguished scientist with expertise spanning green chemistry, renewable energy, carbohydrate chemistry, glycobiology, ionic liquids, spectroscopy, medicinal chemistry, and synthetic developments. With a multicultural background and fluency in multiple languages, she has built a global research profile, contributing significantly to sustainability and pharmaceutical sciences. Currently serving as a Research Scientist at CSIRO in Australia, she leads and supports projects focused on sustainable carbon technologies and carbon capture efficiency. Her earlier career included leadership as a CERC Fellow at CSIRO, lecturer roles at the University of Newcastle and University of Sydney, and postdoctoral research at the University of Oxford and University College London. She has published extensively in high-impact journals, authored book chapters, and holds patents in hydrogen production and drug development. Her academic and industrial collaborations highlight her interdisciplinary approach, bridging fundamental research with applied solutions to address pressing global challenges in energy, health, and sustainability.

Profile

Google scholar

ORCID

Education

Dr. Michela Simone earned her Doctor of Philosophy from the University of Oxford, where she conducted pioneering research on branched sugar lactones under the mentorship of Professor George W. J. Fleet at the Dyson Perrins Laboratory and Chemistry Research Laboratory. Prior to this, she completed her Master of Science with first-class honours at the Victoria University of Manchester, focusing on the synthesis of muscarinic receptor agonists under Professor E. James Thomas. During her studies, she was awarded a European Union Socrates Award for an exchange program at the Georg-August University of Göttingen in Germany, where she worked on chemical and biological syntheses of pyripyropenes under Professor Uwe Beifuss. This international academic training provided her with a strong foundation in synthetic organic chemistry, carbohydrate chemistry, and medicinal chemistry. Her educational journey laid the groundwork for her later achievements in spectroscopy, drug discovery, and renewable energy research, demonstrating her ability to bridge chemistry with interdisciplinary applications.

Experience

Dr. Michela Simone’s professional journey reflects a balance of academic scholarship, research innovation, and industrial collaboration. Currently, she works at CSIRO as a Research Scientist in the Sustainable Carbon Technologies Group, where she applies her mechanistic and spectroscopic expertise to optimize carbon capture processes for industrial applications. Previously, as a CERC Fellow at CSIRO, she led a major project on sustainable hydrogen production, integrating physical chemistry, engineering, and physics, resulting in a patent for water-splitting processes. Her academic career includes tenure as a Lecturer in Medicinal Chemistry and Chemical Biology at the University of Newcastle, where she managed a 40:40:20 workload across research, teaching, and service while supervising her research group in glycobiology and synthetic chemistry. Earlier, she was a Lecturer in Chemistry at the University of Sydney, focusing on medicinal and biological chemistry. Her postdoctoral work at Oxford and University College London contributed to advances in protein interactions and medicinal chemistry.

Awards and Honors

Dr. Michela Simone’s career has been marked by recognition for her contributions to chemistry and interdisciplinary research. She has authored more than sixty-five peer-reviewed publications, invited book chapters, and holds patents in hydrogen production technologies and drug delivery systems, reflecting her innovative impact on both energy and healthcare. Her invited contributions to special issues in journals such as Molecules, Pharmaceuticals, and the European Journal of Medicinal Chemistry highlight her status as a recognized expert in boron chemistry, glycobiology, and green synthetic methods. She has been invited to contribute book chapters with leading publishers including Taylor & Francis, underscoring her international reputation. Her work has been spotlighted in editorial features such as “Women in Bioorganic Chemistry,” reflecting her role as a leader and role model in science. With a growing citation record, high h-index, and strong collaborations across academia and industry, she continues to be acknowledged for her research excellence and scientific leadership.

Research Focus

Dr. Michela Simone’s research focus lies at the intersection of green chemistry, renewable energy, and medicinal chemistry, with an emphasis on practical applications that address urgent global challenges. She has pioneered work in renewable fuels, including hydrogen generation, biomass conversion, carbon capture and storage, and redox flow batteries, aiming to reduce environmental impact while improving energy efficiency. Her work in carbohydrate chemistry and glycobiology has contributed to the development of high and low Fsp3 drug leads, with innovative approaches incorporating organic boron as a novel pharmacophore for medicinal chemistry and cancer therapies. She has also advanced the field of ionic liquids, exploring their potential in sustainable synthesis and material applications. Utilizing spectroscopy and mechanistic insights, she combines fundamental chemical principles with applied solutions, leading to patents and industrial collaborations. Her interdisciplinary approach integrates chemistry, physics, and engineering, establishing her as a global leader in research that bridges sustainability, energy innovation, and health.

 

Publications

 

Title: Endothelial C-type natriuretic peptide maintains vascular homeostasis
Year: 2014
Citation: 187

Title: The expanding utility of continuous flow hydrogenation
Year: 2015
Citation: 144

Title: Synchrotron based NEXAFS study on nitrogen doped hydrothermal carbon: Insights into surface functionalities and formation mechanisms
Year: 2017
Citation: 126

Title: A compendium of sugar amino acids (SAA): scaffolds, peptide-and glyco-mimetics
Year: 2007
Citation: 121

Title: Selective inhibition of the mitochondrial permeability transition pore protects against neurodegeneration in experimental multiple sclerosis
Year: 2016
Citation: 111

Title: A compendium of cyclic sugar amino acids and their carbocyclic and heterocyclic nitrogen analogues
Year: 2013
Citation: 103

Title: Kiliani on ketoses: branched carbohydrate building blocks from D-fructose and L-sorbose
Year: 2004
Citation: 87

Title: Kiliani reactions on ketoses: branched carbohydrate building blocks from D-tagatose and D-psicose
Year: 2005
Citation: 79

Title: o-Vanillin Derived Schiff Bases and Their Organotin(IV) Compounds: Synthesis, Structural Characterisation, In-Silico Studies and Cytotoxicity
Year: 2019
Citation: 52

Conclusion

Dr. Michela Simone is an accomplished scientist whose interdisciplinary expertise in green chemistry, renewable energy, carbohydrate chemistry, and medicinal chemistry has led to impactful research, patents, and collaborations that advance sustainability and healthcare innovation worldwide.

Manijeh Beigi | Medical Physics | Best Researcher Award

Dr. Manijeh Beigi | Medical Physics | Best Researcher Award

Dr. Manijeh Beigi is an Assistant Professor in the Radiation Oncology Department at Iran University of Medical Sciences. She specializes in dosimetry, radiotherapy treatment planning, and quality audits, with a focus on using machine learning for radiomics and dosiomics analysis. Dr. Beigi earned her Ph.D. in Medical Physics from Tehran University of Medical Sciences in 2018, where she researched the application of Diffusion Tensor Imaging (DTI) in radiotherapy planning. With over a decade of experience in radiotherapy physics, she has worked in multiple hospitals, including Imam Hosein, Haft-e-Tir, and Pardis Niloo Cancer Center. She is actively involved in research on predicting radiotherapy toxicity and advanced MR imaging applications. Dr. Beigi has mentored numerous students, contributed to high-impact journals, and presented at international conferences. Her research aims to enhance radiotherapy precision and patient safety through cutting-edge imaging and AI-driven models. 🎓🔬

Profile

Education 🎓

Dr. Manijeh Beigi holds a Ph.D. in Medical Physics (2018) from Tehran University of Medical Sciences, where she developed automated clinical target volume determination for glioma treatment using multiparametric MRI. She completed her M.Sc. in Medical Physics (2010) at Tarbiat Modares University, focusing on radiotherapy dosimetry and quality audits in Varian linear accelerators. Her coursework covered key topics such as radiotherapy physics, radiobiology, MRI, CT, and PET physics, statistical methods, and treatment planning. Throughout her academic journey, she has specialized in advanced imaging techniques, radiomics, and AI-based predictive modeling for radiotherapy applications. Dr. Beigi’s education has provided her with strong expertise in medical physics, treatment planning optimization, and quality assurance, positioning her as a leader in radiation oncology research and innovation. 📚

Experience 👨‍🏫

Dr. Manijeh Beigi has been an Assistant Professor at Iran University of Medical Sciences since 2020, where she focuses on radiotherapy physics, treatment planning, and quality assurance. Previously, she worked as a Radiotherapy Physicist at Imam Hosein Hospital (2010-2016), Haft-e-Tir Hospital (2016-Present), and Pardis Niloo Cancer Center (2019-2021), specializing in 3D conformal radiotherapy, IMRT planning, machine QA, and dosimetry. She was also a Research Assistant (2012-2018) at Tehran University of Medical Sciences, collaborating on quantitative MRI and spectroscopy research. Dr. Beigi has significant experience in mentoring students, managing research projects, and implementing AI-driven radiotherapy solutions. Her work integrates imaging and machine learning to optimize treatment efficacy and minimize patient toxicity. 💼🔬

Research Interests 🔬

Dr. Manijeh Beigi’s research centers on dosimetry, radiotherapy quality audits, and the application of machine learning in radiomics and dosiomics. She explores AI-driven models to predict radiotherapy toxicity and optimize treatment planning. Her work integrates advanced MRI techniques, such as Diffusion Tensor Imaging (DTI), to enhance clinical target volume delineation for gliomas and other cancers. She investigates imaging biomarkers to assess radiation-induced damage and improve treatment precision. Additionally, Dr. Beigi is actively involved in multi-disciplinary research collaborations, utilizing deep learning for medical image analysis. Her contributions aim to advance radiation oncology by improving accuracy, reducing side effects, and personalizing treatment plans. 🧬📡

Dr. Manijeh Beigi has received several accolades for her contributions to medical physics and radiotherapy research. She has been recognized for her work in AI-driven radiomics and dosiomics at international conferences, including ESTRO and AAPM. Her research on glioma segmentation using DTI and radiotherapy toxicity prediction has been published in top-tier journals. She has also been awarded grants for her studies on advanced MRI applications in radiotherapy planning. Additionally, Dr. Beigi has played a key role in multi-institutional research collaborations, earning recognition for her leadership in medical imaging and quality assurance. 🏆🎖️

Publications 📚